Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH Biotech Investing
Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome Pharmaceutical Investing
Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M Pharmaceutical Investing
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva Biotech Investing
GW Pharmaceuticals Reports Fiscal First Quarter 2018 Financial Results and Operational Progress Life Science Investing
Sol-Gel Technologies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Longevity Investing
PolarityTE™ Provides Business Updates on Clinical Use of SkinTE: Regeneration of Full-Thickness Skin Pharmaceutical Investing
EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery Pharmaceutical Investing
